Acute Myocardial Infarction (AMI) is the leading cause of mortality in both developed and developing countries. 1,2 Acute coronary syndromes are emerging out in epidemic proportions throughout the world. Factors contributing to death following acute myocardial infarction are many.
Hence, many trials have been conducted to identify markers that would be helpful to predict the risk of such adverse cardiac events.
Many trials have used serum Magnesium level, 7 C-reactive protein levels, 8 malonyl dialdehyde, 9 white blood cell count 9 as a predictor for mortality and morbidity following acute myocardial infarction and risk of developing adverse cardiac events like sudden cardiac death and congestive heart failure.
Previous studies have established that Serum Uric Acid (SUA) levels reflect circulating xanthine oxidase activity and oxidative stress production following acute myocardial infarction.
Free radicals produced in large amounts during myocardial ischaemia and reperfusion, take part in the degradation of cellular and subcellular membrane structures. The source of oxygen radicals in ischaemic myocardium are neutrophils recruited into the necrotic region as well as metabolic transformation of Hypoxanthine and Xanthine to Uric acid. 9 Thus, it is evident that elevated Uric Acid (UA) levels is a good marker of oxidative stress and useful to assess the prognostic events in acute myocardial infarction.
This forms the basis of the study.
AIMS OF THE STUDY
1. To assess the prognostic significance of serum uric acid level in acute myocardial infarction. 2. To assess the prognostic significance of serum uric acid levels with incidence of cardiac failure. 3. To validate the prognostic significance between quantitative serum uric acid level on admission and high Killip's class status in acute myocardial infarction. 4. To assess the prognostic significance of serum uric acid levels with incidence of short-term mortality.
MATERIALS AND METHODS Study Population
This study was conducted in the Department of Medicine 
Study Design
This study is a prospective study. This study is aimed to assess the prognostic role of serum uric acid level following acute myocardial infarction and correlating the levels with shortterm complications. This study included 100 patients of acute myocardial infarction of which patients who had a normal uric acid level were taken as a population with normal serum uric acid and the rest who had elevated uric acid level were taken up as a population with hyperuricaemia.
In both groups, the complications and short-term outcome were compared.
Inclusion Criteria
Patients with a diagnosis of acute ST Elevation Myocardial Infarction were entered into the study. A definite diagnosis of acute ST Elevation Myocardial Infarction was made if the patients satisfied the following criteria: A history of typical retrosternal compressive chest pain lasting for more than 30 minutes, not relieved by rest or nitrates. Typical ECG changes of acute ST Elevation Myocardial Infarction. Qualifying patients received thrombolytic therapy with 1.5 million units of streptokinase followed by heparin for 5-7 days.
Exclusion Criteria
Assessment of left ventricular ejection fraction by echocardiography was performed either on day 4 or 5 of hospitalisation in most patients or earlier if clinically indicated.
Uric Acid Estimation
Immediately after admission, blood sample of 3 cc was drawn by venepuncture and transferred to dry plain bottle and taken to biochemistry laboratory.
The method used for analysis is enzymatic method (Uricase method) by using autoanalyser.
In our laboratory, values taken as normal range.
For Males : 3.4 -7.0 mg/dL For Females : 2.4 -6.0 mg/dL Methodology Methods using uricase, the enzyme that catalyses the oxidation of uric acid to allantoin are most specific. The simplest of these methods measures the differential absorption of uric acid and allantoin at 293 nm. 10 The difference in absorbance before and after incubation with uricase is proportional to the uric acid concentration. This method has been proposed as candidate reference method. 11 This method was done in our study. This is the most specific method.
Followup
All the patients were followed up for a period of 7 days. During followup, any changes in Killip's classification, features of cardiac failure and any mortality were noted in both groups of patients. Routine daily physical examination was done. ECGs were taken daily and additional investigations carried out if necessary. Patients were discharged on 8 th day if they were stable, otherwise their hospital stay was prolonged.
Framingham criteria for heart failure like JVP elevation, basal rales, acute pulmonary oedema, S3 gallop, tachycardia (>100/min.), lower extremity oedema were used in this study for making a diagnosis of CCF. 12
OBSERVATIONS AND RESULTS
The study population consisted of 100 patients with 77 males and 23 females. All patients belonged to places around Warangal District. All patients were admitted in Intensive Cardiac Care Unit initially for 5 days, then cared in adjoining intermediate cardiac care ward and discharged after an average period of 7 days provided there were no complications. Table 9 
: Proportion of Heart Failure Contributed by Patients with High & Normal Serum Uric Acid Level
It is observed that patients with high uric acid level contribute 73% (30×100÷41) to the total incidence of heart failure whereas patients with normal uric acid contributes to 27% only.
No. of Patients with High Serum Uric Acid Level
No. of Patients with Heart Failure 47 30 Contribution of patients with high serum uric acid level to arrhythmias: 71% Contribution of patients with normal serum uric acid levels to arrhythmias: 29%.
It is observed that patients with high SUA level contribute 71% to the total incidence of arrhythmias.
No. of Patients with
High SUA
Arrhythmias 47 5 
21: Proportion of Mortality Contributed by Patients with High & Normal Serum Uric Acid Level
It is observed that patients with high uric acid level contribute 80% to the total incidence of mortality (12×100÷15=80%) and patients with normal serum uric acid levels contribute 20% to the total incidence of mortality (3×100÷15=20).
No. of Patients with High Serum Uric Acid Level No. of Deaths

12 Table 22: Incidence of Mortality in Patients with High Serum Uric Acid Level
Incidence (12×100÷47)=26%. i.e. 26% of patients with high uric acid level died in the study.
No. of Patients with Normal Uric Acid Level
No. of Deaths
3 Table 23: Incidence of Mortality in Patients with Normal Serum Uric Acid Level
Incidence (3×100÷53)=6%. i.e. 6% patients with normal uric acid level died in the study.
DISCUSSION
Total number of patients included in this study was 100, out of which 47 patients had elevated levels of uric acid above normal range and 53 patients had normal serum uric acid levels following acute myocardial infarction.
The significance level between two parameters is assessed with p value calculated by applying Chi-square test.
Age
Of the 100 patients, 10 patients were in the age group of 31-40 years, 22 patients were in the age group of 41-50 years, 37 patients were in the age group of 51-60 years, 24 patients were in the age group of 61-70 years, 7 patients were in the age group of 71-80 years. (Table 1 ).
The Results of Other Studies as Follows
Age in Years
High Uric Acid Normal Uric Acid Present Study 59.55 58. 16 Agarwal S et al 13 60.59 58.90
The mean ages in hyperuricaemic population and in normouricaemic population were 59.55 years, 58.16 years respectively in this study.
Present study results are comparable with Agarwal S et al study.
Sex Ratio (Table 2)
In this study, male and female ratios were 3.34:1, 2.12:1 and 4.2:1 in total population, hyperuricaemic population and normouricaemic population respectively. Present study correlates with MY Nadkar et al study.
High Uric Acid Normal Uric Acid
Population with Hyperuricaemia & Population with Normouricaemia
Out of 100 patients studied, 53 patients had normal uric acid level and they were taken up as patients with normal serum uric acid. Of which 43 (81%) were males and 10 (19%) were females. The rest 47 patients had elevated serum uric acid level and they were taken up as patients with hyperuricaemia. Of which 34 (72.3%) were males and 13 (27.7%) were females. Both were compared with various outcomes.
Distribution of Patients According to Serum Uric Acid
Level & Sex-in Total Population ( The results of this study showed significant association between high serum uric acid levels and higher Killip class (III &IV) of heart failure (p <0.05).
Shoba Shetty et al 15 showed that in patients with higher Killip class (III & IV), there were high serum uric acid levels (p <0.001).
MY Nadkar, VI Jain et al also found similar results between high serum uric acid levels and higher Killip class (III & IV).
Present study correlates with above studies and Kojima S, Sakamoto et al, (American Journal of Cardiology, 2005 Aug. 15) who also showed patients who had high uric acid level belonged to higher Killip class. Hence, uric acid can also be used as a predictor of prognosis.
Heart Failure 41 out of 100 patients in this study had heart failure in the post-myocardial infarction period. So the incidence of heart failure was 41%. Of which 28 (68.2%) were males, 13 (31.8%) were females. (Table 7 & 8) .
It was observed that among 41 heart failure patients, 30 patients had high uric acid level and 11 patients had normal uric acid level. So patients who had high uric acid level and normal uric acid level contributed to 73% and 27% respectively to heart failure (Table 9 ).
It was also found that 30 patients out of 47 patients with high uric acid level had heart failure amounting to an incidence of 64% heart failure in this group (Table 10) .
While only 11 out of 53 patients with normal uric acid level had heart failure. i.e. only 21% of patients with normal uric acid level had heart failure (Table 11) .
Present study correlates with other studies who showed similar findings and elevated serum uric acid level is an early predictor of short-term outcome.
The results of other studies are as follows. studies support this study. Their studies revealed that serum uric acid level reflects circulatory xanthine oxidase activity and oxidative stress production. Increased serum uric acid level has been identified in patients who have congestive cardiac failure and is a marker of poor prognosis in such patients.
Echocardiogram
In high uric acid population, 17 (36%) patients had LVEF <50% and 30 (64%) patients had LVEF >50% whereas in normal uric acid level population, 8 patients had LVEF <50% and 45 patients had LVEF >50% (Table 12) .
Among 17 hyperuricaemia patients, 16 (85%) are males and 9 (53%) are females. Patients who had elevated serum uric acid level, hyperuricaemia is significantly associated with LVEF <50% (p <0.05). Present study results are similar to results of reference study. So uric acid level can be used as a definite predictor of cardiac failure. Arrhythmias 7 out of 100 patients developed arrhythmias in this study. So the incidence of arrhythmias was 7% of which 6 (86%) were males, 1 (14%) was female. 3 patients had ventricular tachycardia and 4 patients had supraventricular tachycardia (Table 13 & 14) .
Results of other studies are as follows
It was observed that among 7 arrhythmias, 5 patients had high uric acid level and 2 patients had normal uric acid level. So patients who had high uric acid level and normal uric acid level contributed to 71% and 29% respectively to arrhythmias (Table 15 ).
It was also found that 5 patients out of 47 patients with high uric acid level had arrhythmias amounting to an incidence of 11% arrhythmias in this group while only 2 out of 53 patients with normal uric acid level had arrhythmias i.e. only 4 % of patients with normal uric acid level had arrhythmias. (Table 16 & 17) .
